UCLA Health Beverly Hills Primary & Specialty Care
Welcome,         Profile    Billing    Logout  
 5 Trials 
8 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Sedrak, Mina
NCT00609791: Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients of Different Ages With Metastatic Breast Cancer

Active, not recruiting
2
40
US
paclitaxel albumin-stabilized nanoparticle formulation, pharmacological study, physiologic testing, questionnaire administration, study of socioeconomic and demographic variables, cognitive assessment, psychosocial assessment and care
City of Hope Medical Center, National Cancer Institute (NCI)
Breast Cancer
10/11
12/24
NCT01463072: Nab-Paclitaxel in Treating Older Patients With Locally Advanced or Metastatic Breast Cancer

Active, not recruiting
2
40
US
Laboratory Biomarker Analysis, Nab-paclitaxel, ABI 007, ABI-007, Abraxane, Albumin-bound Paclitaxel, Albumin-Stabilized Nanoparticle Paclitaxel, Nanoparticle Albumin-bound Paclitaxel, Nanoparticle Paclitaxel, Paclitaxel Albumin, paclitaxel albumin-stabilized nanoparticle formulation, protein-bound paclitaxel, Questionnaire Administration
City of Hope Medical Center, National Cancer Institute (NCI)
Locally Advanced Breast Carcinoma, Metastatic Breast Carcinoma, Recurrent Breast Carcinoma, Stage III Breast Cancer AJCC v7, Stage IIIA Breast Cancer AJCC v7, Stage IIIB Breast Cancer AJCC v7, Stage IIIC Breast Cancer AJCC v7, Stage IV Breast Cancer AJCC v6 and v7
05/17
12/24
NCT03633331: Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer

Active, not recruiting
2
93
US
Palbociclib, Letrozole, Fulvestrant, Questionnaire Administration, Quality-of-Life Assessment
Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI)
Estrogen Receptor-positive Breast Cancer, HER2/Neu Negative, Stage IV Breast Cancer AJCC v6 and v7
09/20
08/24
NCT03477396: Ribociclib and Aromatase Inhibitor in Treating Older Participants With Hormone Receptor Positive Metastatic Breast Cancer

Completed
2
2
US
Aromatase Inhibitor, Androstenedione Aromatase Inhibitor, Estrogen Synthase Inhibitor, Estrogen Synthetase Inhibitor, Laboratory Biomarker Analysis, Pharmacokinetic Study, PHARMACOKINETIC, PK Study, Questionnaire Administration, Ribociclib, Kisqali, LEE-011, LEE011
City of Hope Medical Center, National Cancer Institute (NCI)
Estrogen Receptor and/or Progesterone Receptor Positive, HER2/Neu Negative, Stage IV Breast Cancer AJCC v6 and v7
09/21
06/23
NCT04305834: Abemaciclib and Endocrine Therapy in Older Patients with Breast Cancer.

Recruiting
2
43
US
Abemaciclib, LY-2835219, LY2835219, Verzenio, Questionnaire Administration
City of Hope Medical Center, National Cancer Institute (NCI)
Anatomic Stage IV Breast Cancer AJCC V8, Hormone Receptor Positive Breast Carcinoma, Metastatic Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC V8
08/25
08/25
TROFFi, NCT05595499: Fisetin to Improve Physical Function in Stage I-III Breast Cancer Survivors

Recruiting
2
88
US
Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Fisetin, 3,3',4',7-Tetrahydroxyflavone, 7,3',4'-Flavon-3-ol, Placebo Administration, Quality-of-Life Assessment, Quality of Life Assessment, Questionnaire Administration
Jonsson Comprehensive Cancer Center, National Cancer Institute (NCI), National Institute on Aging (NIA)
Anatomic Stage I Breast Cancer AJCC V8, Anatomic Stage II Breast Cancer AJCC V8, Anatomic Stage III Breast Cancer AJCC V8
06/26
06/26
NCT06113016: Prevention of Frailty with Fisetin and Exercise (PROFFi) in Breast Cancer Survivors

Recruiting
2
164
US
Biospecimen Collection, Biological Sample Collection, Biospecimen Collected, Specimen Collection, Educational Intervention, Education for Intervention, Intervention by Education, Intervention through Education, Intervention, Educational, Exercise Intervention, Fisetin, 3,3',4',7-Tetrahydroxyflavone, 7,3',4'-Flavon-3-ol, Physical Performance Testing, Physical Fitness Testing, Physical Function Testing, Placebo Administration, Quality-of-Life Assessment, Quality of Life Assessment, Questionnaire Administration
Jonsson Comprehensive Cancer Center, National Institutes of Health (NIH), National Cancer Institute (NCI)
Anatomic Stage I Breast Cancer American Joint Committee on Cancer (AJCC) V8, Anatomic Stage II Breast Cancer AJCC V8, Anatomic Stage III Breast Cancer AJCC V8, Early Stage Breast Carcinoma
08/28
08/31
NCT01472094: The Hurria Older PatiEnts (HOPE) With Breast Cancer Study

Active, not recruiting
N/A
700
US
City of Hope Medical Center, National Institutes of Health (NIH), National Institute on Aging (NIA)
Breast Cancer
12/18
12/24

Download Options